We are live on
!
Find out more
CCM
Cadence Capital Management Portfolio holdings
AUM
$415M
1-Year Est. Return
11.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.16%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
–
AUM
$1.37B
AUM Growth
+$44.5M
(+3.4%)
Cap. Flow
-$9.6M
Cap. Flow
% of AUM
-0.7%
Top 10 Holdings %
Top 10 Hldgs %
10.12%
Holding
687
New
99
Increased
230
Reduced
280
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.2M |
| 2 |
Gilead Sciences
GILD
|
+$11.6M |
| 3 |
ConocoPhillips
COP
|
+$5.98M |
| 4 |
Morgan Stanley
MS
|
+$5.54M |
| 5 |
Capri Holdings
CPRI
|
+$3.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$11.9M |
| 2 |
American International
AIG
|
+$11.1M |
| 3 |
Texas Instruments
TXN
|
+$9.03M |
| 4 |
Prudential Financial
PRU
|
+$7.31M |
| 5 |
General Motors
GM
|
+$6.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.46% |
| 2 | Industrials | 14.03% |
| 3 | Technology | 11.99% |
| 4 | Healthcare | 11.73% |
| 5 | Consumer Staples | 11.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HSKA
276
DELISTED
Heska Corp
HSKA
| $1.17M | 0.09% |
21,411
-148
| -0.7% | -$7.3K |
|
277
Targa Resources
TRGP
$56.8B
| $1.16M | 0.08% |
23,686
+1,232
| +5% | +$53.5K |
|
|
AUTO
278
DELISTED
AutoWeb, Inc. Common Stock
AUTO
| $1.16M | 0.08% |
65,305
+9,038
| +16% | +$145K |
|
|
HCCI
279
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $1.15M | 0.08% |
86,607
+10,994
| +15% | +$142K |
|
|
CA
280
DELISTED
CA, Inc.
CA
| $1.15M | 0.08% |
34,722
-11,186
| -24% | -$377K |
|
281
C.H. Robinson
CHRW
$17.2B
| $1.14M | 0.08% |
16,177
-3,055
| -16% | -$214K |
|
|
TMX
282
DELISTED
Terminix Global Holdings, Inc.
TMX
| $1.14M | 0.08% |
50,366
-38
| -0.1% | -$956 |
|
|
CTXS
283
DELISTED
Citrix Systems Inc
CTXS
| $1.12M | 0.08% |
16,514
-12
| -0.1% | -$817 |
|
284
ANI Pharmaceuticals
ANIP
$1.82B
| $1.12M | 0.08% |
16,829
-112
| -0.7% | -$7K |
|
285
Packaging Corp of America
PKG
$22.4B
| $1.11M | 0.08% |
13,622
-2,286
| -14% | -$175K |
|
|
ZAGG
286
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $1.1M | 0.08% |
135,632
+17,173
| +14% | +$120K |
|
|
BEAT
287
DELISTED
BioTelemetry, Inc.
BEAT
| $1.1M | 0.08% |
59,061
+8,965
| +18% | +$169K |
|
288
Cavco Industries
CVCO
$4.2B
| $1.09M | 0.08% |
11,017
+3,045
| +38% | +$304K |
|
289
NeoGenomics
NEO
$2.04B
| $1.09M | 0.08% |
132,665
+43,970
| +50% | +$369K |
|
|
DSPG
290
DELISTED
DSP Group Inc
DSPG
| $1.08M | 0.08% |
90,002
-15,777
| -15% | -$176K |
|
|
SCMP
291
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $1.08M | 0.08% |
87,674
+63,795
| +267% | +$752K |
|
292
Advanced Drainage Systems
WMS
$11.1B
| $1.08M | 0.08% |
44,803
+6,634
| +17% | +$169K |
|
|
GPX
293
DELISTED
GP Strategies Corp.
GPX
| $1.07M | 0.08% |
+43,576
| New | +$1.01M |
|
294
Fidelity National Financial
FNF
$13.9B
| $1.07M | 0.08% |
41,609
-7,664
| -16% | -$198K |
|
|
OPLN
295
Openlane
OPLN
$4.36B
| $1.06M | 0.08% |
64,880
-95,954
| -60% | -$1.53M |
|
296
Silvercrest Asset Management
SAMG
$80.4M
| $1.05M | 0.08% |
88,134
-620
| -0.7% | -$7.51K |
|
|
SRCI
297
DELISTED
SRC Energy Inc
SRCI
| $1.04M | 0.08% |
150,774
-1,052
| -0.7% | -$6.95K |
|
|
GTT
298
DELISTED
GTT Communications, Inc.
GTT
| $1.04M | 0.08% |
44,220
-307
| -0.7% | -$6.48K |
|
299
General Dynamics
GD
$103B
| $1.04M | 0.08% |
6,680
-329
| -5% | -$49K |
|
300
RPM International
RPM
$14.2B
| $1.03M | 0.08% |
19,260
+5,660
| +42% | +$300K |
|
Similar funds
MGAI
FA
LWS
VCP
AIM
F
CPF
IA
Cadence Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Cadence Capital Management held 687 positions worth $1.37B, up 3.4% from $1.33B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Cadence Capital Management's Q3 2016 filing shows 99 new, 230 increased, 280 reduced and 72 closed positions. Its largest new stake was Bristol-Myers Squibb: 190,283 shares worth $10.3M. The largest sale was Apple, an estimated $11.9M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Technology.
- Cadence Capital Management's largest Q3 2016 buy was Bristol-Myers Squibb: 190,283 shares worth $10.3M.
- Cadence Capital Management added most to Gilead Sciences in Q3 2016, an estimated $11.6M increase.
- Cadence Capital Management's biggest Q3 2016 reduction was Apple, cutting an estimated $11.9M.
- Cadence Capital Management fully exited American International in Q3 2016, selling an estimated $11.1M.
- Cadence Capital Management's ten largest holdings make up 10% of its $1.37B portfolio in Q3 2016.
- Cadence Capital Management opened 99 new positions and closed 72 in Q3 2016.
- Cadence Capital Management's portfolio value rose 3.4% quarter-over-quarter to $1.37B.
Based on Cadence Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.